Torrent Pharmaceuticals Limited
TORNTPHARM
Classificação em ações
#1203
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Preço da ação
$50.16
Valor de mercado
$19.08B
Variação (1 dia)
-0.30%
Variação (1 ano)
22.94%
País
IN
Negociar Torrent Pharmaceuticals Limited (TORNTPHARM)
Categoria
Healthcare
Receita da Torrent Pharmaceuticals Limited (TORNTPHARM)
Receita em Jun 2026 TTM: $1.72B
De acordo com os últimos relatórios financeiros da Torrent Pharmaceuticals Limited, a receita atual da empresa (TTM) é $1.72B. Em 2024, a empresa obteve uma receita de $1.29B um aumento em relação a a receita do ano 2023, que foi de $1.17B. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Torrent Pharmaceuticals Limited de 2005 a 2026
Receita no final de cada ano
| Ano | Receita | Alterar |
|---|---|---|
| 2026 (TTM) | $1.72B | 27.98% |
| 2025 | $1.35B | 4.66% |
| 2024 | $1.29B | 9.91% |
| 2023 | $1.17B | 4.44% |
| 2022 | $1.12B | 2.50% |
| 2021 | $1.09B | 3.76% |
| 2020 | $1.05B | -4.62% |
| 2019 | $1.10B | 20.92% |
| 2018 | $913.81M | 1.90% |
| 2017 | $896.80M | -10.88% |
| 2016 | $1.01B | 34.94% |
| 2015 | $745.76M | -3.94% |
| 2014 | $776.35M | 31.37% |
| 2013 | $590.99M | 15.51% |
| 2012 | $511.64M | 7.45% |
| 2011 | $476.15M | 11.61% |
| 2010 | $426.62M | 32.82% |
| 2009 | $321.20M | -5.13% |
| 2008 | $338.57M | 13.00% |
| 2007 | $299.62M | 37.98% |
| 2006 | $217.15M | 73.11% |
| 2005 | $125.44M | 0.00% |
Receita de empresas similares ou concorrentes
| Empresa | Receita | Diferença de Receita | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 283.67% |
IN
|
